Exploration of the Tumor-Suppressive Immune Microenvironment by Integrated Analysis in <i>EGFR</i>-Mutant Lung Adenocarcinoma.

Front Oncol · 2021 · PMC8200668 · PMID 34136375

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In our study, compared with KRAS and the whole LUAD group, the TIME in the EGFR mutant patients showed a trend of diminishing activated TILs and increasing numbers of immunosuppressive cells.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.